Sitagliptin Phosphate
CAS 654671-77-9Small Molecule
Overview
Sitagliptin Phosphate is an orally active inhibitor of the DPP-4 enzyme, which is involved in glucose metabolism, and is used in the treatment of type 2 diabetes mellitus. It helps to increase insulin production and decrease the amount of sugar made by the body.
Therapeutic areas
EndocrinologyMetabolic DiseasesDiabetology
Verified Supplier Partner
Do you supply Sitagliptin Phosphate? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.